CKD 5D, HEMODIALYSIS
Clinical trials for CKD 5D, HEMODIALYSIS explained in plain language.
Never miss a new study
Get alerted when new CKD 5D, HEMODIALYSIS trials appear
Sign up with your email to follow new studies for CKD 5D, HEMODIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dialysis approach could reduce bleeding risks in kidney patients
Disease control Not yet recruitingThis study compares a new, personalized way of giving a blood thinner (citrate) during kidney dialysis to the standard method. It involves 142 adults with acute kidney injury or advanced chronic kidney disease who also have liver failure or poor blood flow. The goal is to see if …
Matched conditions: CKD 5D, HEMODIALYSIS
Phase: NA • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug could scratch the itch for dialysis patients
Symptom relief Not yet recruitingThis trial tests whether the drug difelikefalin can reduce severe itching in people with chronic kidney disease who are on hemodialysis. About 106 adults will receive either the drug or a placebo after each dialysis session for 6 weeks. The main goal is to see if itching scores i…
Matched conditions: CKD 5D, HEMODIALYSIS
Phase: NA • Sponsor: Chittagong Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC